Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been ...
Covetrus®, the first tech-enabled veterinary practice improvement company, today announced at the VMX 2025 conference (booth #2104) its AI-powered workflow automation and treatment board capabilities ...